Comirnaty® (10 micrograms/dose concentrate) for children aged 5-11

The European Medicines Agency authorised the use of the Comirnaty (10 micrograms/dose concentrate) for children aged 5-11 vaccine in November 2021.

This page contains information to support vaccinators who are administering the Comirnaty® (PfizerBioNTech) COVID-19 mRNA Vaccine.

Children-Comirnaty®-(PfizerBioNTech)-vaccine-Summary-Sheet--(10)

Materials for Vaccinators

Comirnaty (10 micrograms/dose concentrate) for children aged 5-11 vaccine Summary Sheet Version 1
Comirnaty® (Pfizer/BioNTech) Vaccine Formulations Guide Version 2
Self-Assessment of Competency to Administer COVID-19 Vaccine under Medicine Protocol (for nurses and midwives working to a medicines protocol) 26 March 2021
Medicine Protocol for Comirnaty (10 micrograms/dose concentrate) for children aged 5-11 Vaccine (for nurses and midwives working to a medicines protocol) 17 December 2021
Protocol for the Administration of COVID-19 Vaccine by Registered Optometrists under S.I. 081/2021 21 December 2021
Protocol for the Administration of COVID-19 Vaccine by Registered Physiotherapists under S.I.698/2020 and S.I. 081/2021 21 December 2021
Protocol for the Administration of COVID-19 Vaccine by Registered Radiographers and Radiation Therapists under S.I. 245/2021 21 December 2021
Anaphylaxis Management July 2021
SOP - Management of Comirnaty® COVID-19 Vaccine guidance at local hubs Version 9.0 14 December 2021

Training

Healthcare workers can register or log into www.hseland.ie to complete the COVID-19 Vaccination Training Programme - Children aged 5-11 years. The programme is available in the clinical skills catalogue under the National Immunisation Office icon. As this is a vaccine not used in Ireland before it is vital all vaccinators complete the HSELand training programme before vaccinating children.